BioNexus Gene Lab Corp Common stock (BGLC) Stock Price
BGLCStock
$1.20−77.51%52W
Market Cap$3.52M
P/E—
PEG Ratio—
Div yield—
Beta1.96
BGLC Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-56.51%
Price vs S&P 500 (4W)-18.60%
VGM Score30.53
Industry Peers — Health Services(30)
| Symbol | Value Score | Growth Score | Momentum Score | P/E Ratio (Annual) | Revenue Growth TTM (YoY) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
BGLCBioNexus Gene Lab Corp Common stock | B | F | F | — | -67.1% | -81.8% | -32.9% | $1.20 |
| NTRANatera, Inc. Common Stock | F | A | A | — | 37.8% | -10.7% | -11.7% | $393.44 |
| DGXQuest Diagnostics Inc. | C | D | B | 26.1x | 9.9% | 14.1% | 14.5% | $235.00 |
| LHLabcorp Holdings Inc. | C | D | B | 29.4x | 6.4% | 10.4% | 11.6% | $317.95 |
| GHGuardant Health, Inc. Common Stock | F | A | B | — | 42.7% | -40.2% | -246.6% | $158.60 |
| CAICaris Life Sciences, Inc. Common Stock | F | A | B | — | 38.5% | 12.7% | 18.8% | $30.56 |
| RDNTRadNet, Inc. Common Stock | D | C | C | 1779.3x | 18.9% | 3.0% | -1.9% | $68.80 |
| GRALGRAIL, Inc. Common Stock | D | B | B | — | 23.1% | -338.4% | -15.9% | $117.81 |
| BLLNBillionToOne, Inc. Class A Common Stock | F | F | C | 621.1x | — | 10.9% | 8.9% | $98.12 |
| VCYTVeracyte, Inc. | D | B | C | 52.2x | 17.3% | 19.6% | 8.6% | $43.12 |
| CDNACareDx, Inc. | D | B | A | 18.3x | 34.4% | 23.6% | 32.8% | $64.00 |
About BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp supplies chemical raw materials to industrial, medical, automotive, and electronics manufacturers across Southeast Asia, while developing non-invasive liquid biopsy tests that analyze RNA to detect early disease biomarkers. The Company's blood-based tests are designed to reduce treatment costs and improve patient management through early disease identification.